CME and CFTC at Odds Over On-Chain Perpetual Futures

The Commodity Futures Trading Commission's recent approval of crypto perpetual futures has ignited a fierce dispute with the CME Group, the largest derivatives exchange operator in the US. The CME has filed a lawsuit against the CFTC, arguing that the regulator has mislabeled the products and is misapplying the law. The CME claims that perpetual futures, which allow traders to take a position on an asset's price without an expiration date, are harmful to its traditional futures products and were approved without proper consideration of the implications. The CFTC, on the other hand, believes that its decision to allow these products will promote innovation and competition in the derivatives market. The lawsuit has significant implications for the US approach to regulating the rapidly growing market for perpetual futures, with non-US volume reportedly reaching $60 trillion last year. The CME's lawsuit argues that the CFTC's approval of perpetual futures did not follow the proper protocol and may not be enforceable, particularly with regards to blocking non-US traders from participating in these markets. The CFTC's chairman, Mike Selig, has defended the agency's decision, stating that the CME's opposition is 'wholly inappropriate'. The dispute highlights the tension between traditional derivatives exchanges and the emerging market for blockchain-based perpetual futures, with some arguing that the CME is attempting to stifle innovation and competition. The outcome of the lawsuit will have significant implications for the future of the derivatives market and the regulation of perpetual futures.